ereprof. dr. Alain Verstraete
- ORCID iD
-
0000-0002-0956-3315
Show
Sort by
-
Pretomanid-resistant tuberculosis
-
- Journal Article
- A1
- open access
Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients : a prospective single center observational study
-
- Journal Article
- A1
- open access
Organisation and quality monitoring for point-of-care testing (POCT) in Belgium : proposal for an expansion of the legal framework for POCT into primary health care
-
Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme
-
- Journal Article
- A1
- open access
Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
-
Suboptimal beta-lactam therapy in critically ill children : risk factors and outcome
-
- Journal Article
- A1
- open access
Therapeutic drug monitoring of tyrosine kinase inhibitors using dried blood microsamples
-
- Journal Article
- A1
- open access
First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass
-
Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)
-
Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces